Literature DB >> 36051638

Appropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease.

Spencer C Hiller1, Stephanie Daignault-Newton1, Ivan Rakic2, Susan Linsell1, Bronson Conrado1, S Mohammad Jafri3, Ronald Rubenstein3, Mazen Abdelhady4, C Peter Fischer5, Elena Gimenez6, Richard Sarle7, William W Roberts1, Conrad Maitland8, Rafid Yousif9, Robert Elgin10, Laris Galejs11, Jeremy Konheim6, David Leavitt12, Eric Stockall13, J Rene Fontera14, J Stuart Wolf15, John M Hollingsworth1, Casey A Dauw1, Khurshid R Ghani1.   

Abstract

Objective: To bridge the gap between evidence and clinical judgement, we defined scenarios appropriate for ureteral stent omission after uncomplicated ureteroscopy (URS) using the RAND/UCLA Appropriateness Method (RAM). We retrospectively assessed rates of appropriate stent omission, with the goal to implement these criteria in clinical practice.
Methods: A panel of 15 urologists from the Michigan Urological Surgery Improvement Collaborative (MUSIC) met to define uncomplicated URS and the variables that influence stent omission decision-making. Over two rounds, they scored clinical scenarios for Appropriateness Criteria (AC) for stent omission based on a combination of variables. AC were defined by median scores: 1 to 3 (inappropriate), 4 to 6 (uncertain), and 7 to 9 (appropriate). Multivariable analysis determined the association of each variable with AC scores. Uncomplicated URS cases in the MUSIC registry were assigned AC scores and stenting rates assessed.
Results: Seven variables affecting stent decision-making were identified. Of the 144 scenarios, 26 (18%) were appropriate, 88 (61%) inappropriate, and 30 (21%) uncertain for stent omission. Most scenarios appropriate for omission were pre-stented (81%). Scenarios with ureteral access sheath or stones >10mm were only appropriate if pre-stented. Stenting rates of 5,181 URS cases correlated with AC scores. Stents were placed in 61% of cases appropriate for omission (practice range, 25% to 98%).
Conclusion: We defined objective variables and AC for stent omission following uncomplicated URS. AC scores correlated with stenting rates but there was substantial practice variation. Our findings demonstrate that the appropriate use of stent omission is underutilized.

Entities:  

Keywords:  Quality Improvement; Ureteral Stents; Ureteroscopy; Urinary Stone Disease

Year:  2022        PMID: 36051638      PMCID: PMC9432824          DOI: 10.1097/upj.0000000000000302

Source DB:  PubMed          Journal:  Urol Pract        ISSN: 2352-0779


  28 in total

Review 1.  The results of ureteral stenting after ureteroscopic lithotripsy for ureteral calculi: a systematic review and meta-analysis.

Authors:  Shen Pengfei; Li Yutao; Yang Jie; Wei Wuran; Dai Yi; Zeng Hao; Wang Jia
Journal:  J Urol       Date:  2011-09-23       Impact factor: 7.450

2.  Variation in Spending around Surgical Episodes of Urinary Stone Disease: Findings from Michigan.

Authors:  Juan San Juan; Hechuan Hou; Khurshid R Ghani; James M Dupree; John M Hollingsworth
Journal:  J Urol       Date:  2017-11-24       Impact factor: 7.450

Review 3.  Understanding of regional variation in the use of surgery.

Authors:  John D Birkmeyer; Bradley N Reames; Peter McCulloch; Andrew J Carr; W Bruce Campbell; John E Wennberg
Journal:  Lancet       Date:  2013-09-28       Impact factor: 79.321

4.  Characterization of urinary symptoms in patients with ureteral stents.

Authors:  H B Joshi; A Okeke; N Newns; F X Keeley; A G Timoney
Journal:  Urology       Date:  2002-04       Impact factor: 2.649

5.  Ureteral Stent Placement following Ureteroscopy Increases Emergency Department Visits in a Statewide Surgical Collaborative.

Authors:  Spencer C Hiller; Stephanie Daignault-Newton; Hector Pimentel; Sapan N Ambani; John Ludlow; John M Hollingsworth; Khurshid R Ghani; Casey A Dauw
Journal:  J Urol       Date:  2021-02-03       Impact factor: 7.450

6.  A prospective randomized controlled trial comparing nonstented versus stented ureteroscopic lithotripsy.

Authors:  J D Denstedt; T A Wollin; M Sofer; L Nott; M Weir; R J D'A Honey
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

7.  Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative Registry.

Authors:  Udit Singhal; Jeffrey J Tosoian; Ji Qi; David C Miller; Susan M Linsell; Michael Cher; Brian Lane; Michael Cotant; James E Montie; Wassim Bazzi; Mohammad Jafri; Bradley Rosenberg; Arvin K George
Journal:  Urology       Date:  2020-08-07       Impact factor: 2.649

8.  Flexible ureteroscopy with a ureteral access sheath: when to stent?

Authors:  Fabio Cesar Torricelli; Shubha De; Bryan Hinck; Mark Noble; Manoj Monga
Journal:  Urology       Date:  2013-11-12       Impact factor: 2.649

9.  Appropriateness Criteria for Active Surveillance of Prostate Cancer.

Authors:  Michael L Cher; Apoorv Dhir; Gregory B Auffenberg; Susan Linsell; Yuqing Gao; Bradley Rosenberg; S Mohammad Jafri; Laurence Klotz; David C Miller; Khurshid R Ghani; Steven J Bernstein; James E Montie; Brian R Lane
Journal:  J Urol       Date:  2016-07-14       Impact factor: 7.450

10.  Is a ureteral stent required after use of ureteral access sheath in presented patients who undergo flexible ureteroscopy?

Authors:  Gastón Astroza; Manuel Catalán; Lucas Consigliere; Tomás Selman; José Salvadó; Francisco Rubilar
Journal:  Cent European J Urol       Date:  2016-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.